Shichiri Keiko, Oshi Masanori, Ziazadeh Danya, Endo Itaru, Takabe Kazuaki
Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center Buffalo, NY 14263, USA.
U.S. Naval Hospital Okinawa Okinawa, FPO, AP 96362, Japan.
Am J Cancer Res. 2023 Jul 15;13(7):3027-3040. eCollection 2023.
MicroRNAs are small non-coding RNAs that epigenetically regulate gene expression. MiR-200c is a known tumor suppressive microRNA found in many types of cancer, and its high expression has been associated with improved prognosis. However, the association between miR-200c expression and its clinical relevance in gastric cancer (GC) patients remains controversial. Here, we hypothesized that gastric cancer patients with high miR-200c gene expression translated to better overall survival. A total of 372 GC patients from the Cancer Genome Atlas (TCGA) were analyzed. The top three quartiles were defined as a high miR-200c expression group. High miR-200c expression was associated with decreased invasion, favorable histological type, and improved overall survival in gastric cancer patients. Unexpectedly, high miR-200c expression GC was also associated with enhanced cell proliferation, shown by MKi67 expression, proliferation score, and enrichment of Hallmark cell proliferation-related gene sets (E2F targets, G2M checkpoints, MYC targets v1 and v2) by gene set enrichment assay (GSEA). High miR-200c GC was also associated with a high mutation rate and homologous recombination deficiency. Despite the association with elevated neoantigens, high miR-200c GC was associated with significantly low infiltration of anti-cancer immune cells, decreased immune response, and with suppressed IL2, TNF-α, and IFN- pathways. On the other hand, GC with low miR-200c expression significantly enriched hypoxia, angiogenesis, epithelial-mesenchymal transition (EMT), and TGF-β signaling gene sets, all of which promote cancer progression and metastasis in GSEA. In conclusion, patients with high miR-200c expression GC had better survival despite association with aggressive tumor biology, such as high mutation rates, cell proliferation, and low cancer immunity. Given that low miR-200c GC was associated with hypoxia, angiogenesis, EMT and TGF-β signaling, we cannot help but speculate that the difference in survival by miR-200c expression may be at least partly due to the association between low miR-200c expression and aggressive biology.
微小RNA是一类通过表观遗传调控基因表达的小非编码RNA。MiR-200c是一种已知的肿瘤抑制性微小RNA,在多种癌症中均有发现,其高表达与预后改善相关。然而,miR-200c表达与其在胃癌(GC)患者中的临床相关性之间的关系仍存在争议。在此,我们假设miR-200c基因高表达的胃癌患者总生存期更好。对来自癌症基因组图谱(TCGA)的372例GC患者进行了分析。前三四分位数被定义为miR-200c高表达组。miR-200c高表达与胃癌患者侵袭性降低、组织学类型良好及总生存期改善相关。出乎意料的是,miR-200c高表达的GC还与细胞增殖增强相关,这通过MKi67表达、增殖评分以及基因集富集分析(GSEA)显示的特征性细胞增殖相关基因集(E2F靶点、G2M检查点、MYC靶点v1和v2)富集得以体现。miR-200c高表达的GC还与高突变率和同源重组缺陷相关。尽管与新抗原增加有关,但miR-200c高表达的GC与抗癌免疫细胞的浸润显著降低、免疫反应减弱以及IL2、TNF-α和IFN-通路受抑制相关。另一方面,miR-200c低表达的GC在GSEA中显著富集缺氧、血管生成、上皮-间质转化(EMT)和TGF-β信号基因集,所有这些均促进癌症进展和转移。总之,miR-200c高表达的GC患者生存期更好,尽管其与高突变率、细胞增殖和低癌症免疫力等侵袭性肿瘤生物学特征相关。鉴于miR-200c低表达的GC与缺氧、血管生成、EMT和TGF-β信号相关,我们不禁推测miR-200c表达导致的生存差异可能至少部分归因于miR-200c低表达与侵袭性生物学之间的关联。